ProKidney Corp. (PROK)
1.75
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.755
0.00 (0.00%)
Pre-Market: 09:06
ProKidney Total Assets (Quarterly) : 292.78M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 17.43M |
| Karyopharm Therapeutics, Inc. | 131.42M |
| Rocket Pharmaceuticals, Inc. | 285.41M |
| ARS Pharmaceuticals, Inc. | 287.57M |
| Korro Bio, Inc. | 183.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.68M |
| Shareholders Equity (Quarterly) | -1.024B |
| Debt to Equity Ratio | -0.0037 |
| Current Ratio | 9.059 |
| Net Debt Paydown Yield | -0.04% |